a public good project by the
Synthesis
Company
of California

© 2026

Hubert Schrezenmeier | doi.page

0 works0 citations0 h-index

Hubert Schrezenmeier

German Red Cross(DE)

Publications by Year

Research Areas

Complement system in diseases, Hematopoietic Stem Cell Transplantation, Blood groups and transfusion, Mesenchymal stem cell research, Renal Diseases and Glomerulopathies

Most-Cited Works

→ The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria(2006)1,254 cited
→ SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies(2021)1,040 cited
→ Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria(2007)648 cited
→ Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria(2007)576 cited
→ Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation(2012)571 cited
Aplastic Anemia(1999)
→ Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine(1991)422 cited

→ T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.(1988)422 cited

→ Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study(2018)389 cited

→ Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria(2013)384 cited